Medicare Enrolled

Dr. Crystal Broussard, MD

Gastroenterology · Emerson, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
466 OLD HOOK RD, Emerson, NJ 07630
2019678221
In practice since 2006 (20 years)
NPI: 1114955846 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Broussard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Broussard? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Broussard

Dr. Crystal Broussard is a gastroenterology specialist in Emerson, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Broussard performed 334 Medicare services across 300 unique beneficiaries.

Between the years covered by Open Payments, Dr. Broussard received a total of $6,413 from 37 pharmaceutical and/or device companies across 249 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Broussard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 334 Medicare services $6,413 industry payments

Medicare Practice Summary

Medicare Utilization ↗
334
Medicare services
Bottom 20% in NJ for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
300
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~17 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
108 $72 $250
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
38 $198 $1,153
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
35 $156 $1,400
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
32 $46 $154
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
32 $102 $365
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $78 $363
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
21 $106 $1,195
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
17 $50 $258
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
16 $194 $1,151
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
11 $232 $1,457
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,413
Total received (2018-2024)
Avg $916/year across 7 years
Top 22% in NJ for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
249
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,173 (96.3%)
Other
Charitable contributions, space rental, and other categories
$194 (3.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,650
2023
$1,573
2022
$1,432
2021
$471
2020
$154
2019
$760
2018
$374

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$635
PENTAX of America, Inc.
$194
ABBVIE INC.
$148
E.R. Squibb & Sons, L.L.C.
$114
Regeneron Healthcare Solutions, Inc.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$71
Celgene Corporation
$66
PFIZER INC.
$52
Celltrion USA Inc.
$47
Blueprint Medicines Corporation
$41
Merck Sharp & Dohme LLC
$34
Amgen Inc.
$33
Lilly USA, LLC
$32
Phathom Pharmaceuticals, Inc.
$30
QOL Medical, LLC
$24
UCB, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Braintree Laboratories, Inc.
$14
Xeris Pharmaceuticals, Inc.
$13
Top 3 companies account for 59.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,233
Janssen Scientific Affairs, LLC
$715
E.R. Squibb & Sons, L.L.C.
$599
ABBVIE INC.
$584
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$463
Ferring Pharmaceuticals Inc.
$410
Takeda Pharmaceuticals U.S.A., Inc.
$388
AbbVie Inc.
$357
Celgene Corporation
$279
PENTAX of America, Inc.
$194
Amgen Inc.
$180
PFIZER INC.
$143
Ardelyx, Inc.
$142
Regeneron Healthcare Solutions, Inc.
$71
Lilly USA, LLC
$65
Ironwood Pharmaceuticals, Inc
$49
Merck Sharp & Dohme LLC
$48
Celltrion USA Inc.
$47
AbbVie, Inc.
$43
Blueprint Medicines Corporation
$41
Medtronic, Inc.
$37
Allergan Inc.
$36
Braintree Laboratories, Inc.
$34
Synergy Pharmaceuticals Inc
$34
Phathom Pharmaceuticals, Inc.
$30
UCB, Inc.
$29
QOL Medical, LLC
$24
Dexcom, Inc.
$15
Allergan, Inc.
$15
Janssen Pharmaceuticals, Inc
$15
Merck Sharp & Dohme Corporation
$15
Shire North American Group Inc
$15
SOBI, INC
$14
Amarin Pharma Inc.
$14
Xeris Pharmaceuticals, Inc.
$13
Otsuka America Pharmaceutical, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Top 3 companies account for 39.7% of all-time payments
Associated products mentioned in payments ›
APRISO · AYVAKIT · Amitiza · BELSOMRA · BREATHTEK · CIMZIA · CLENPIQ · CREON · Cimzia · DIFICID · DUPIXENT · Dexcom G6 Transmitter · ENTYVIO · EVENITY · Entyvio · HUMIRA · Humira · IBSRELA · JANUVIA · Kineret · LINZESS · Linzess · Livalo · MINIMED 780G · MOUNJARO · MOVIPREP · Mavyret · NATPARA · OMVOH · Prolia · REBYOTA · RECORLEV · REMICADE · RINVOQ · SIMPONI ARIA · SKYRIZI · STELARA · SUCRAID · SUFLAVE · TREMFYA · TRULANCE · Trintellix · Trulance · UCERIS · VELSIPITY · VIBERZI · VIDEO COLONOSCOPE · VOQUEZNA · Vascepa · XARELTO · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Emerson?
Compare gastroenterologists in the Emerson area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
1,095
Per 100K population
114.7
County median income
$123,715
Nearest hospital
HACKENSACK MERIDIAN HEALTH PASCACK VALLEY MEDICAL
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Broussard is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Broussard experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Broussard performed 108 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Broussard receive payments from pharmaceutical companies?
Yes. Dr. Broussard received a total of $6,413 from 37 companies across 249 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Broussard's costs compare to other gastroenterologists in Emerson?
Dr. Broussard's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Broussard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →